Parvus Therapeutics Inc.
PrivateLast Round
Corporate Funding
Mar 20, 2024
Total Funding Raised
$19.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Parvus Therapeutics Inc. is a clinical-stage biotechnology company developing proprietary pMHC nanomedicine drug candidates designed to trigger the in vivo generation of antigen-specific regulatory T cells (Tregs) to treat autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parvus Therapeutics Inc. Comparables
Compare Parvus Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cour Pharma | 86% | |
| Topas Therapeutics | 84% | |
| Anokion | 83% |
Parvus Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 20, 2024 | ||||
| Corporate Funding | Apr 19, 2017 | ||||
| Grant | Jul 30, 2009 |
Parvus Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Innovate Calgary | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 82, 4x the trailing average.
- Jul 20, 2026
Open roles increased to 81, 324% of headcount.
Parvus Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Parvus Therapeutics Inc.'s valuation, stock price, and market status.
Is Parvus Therapeutics Inc. a public or private company?
Parvus Therapeutics Inc. is a private company.
What is the current stock price of Parvus Therapeutics Inc.?
Parvus Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Parvus Therapeutics Inc. worth (valuation)?
Valuation information for Parvus Therapeutics Inc. is not publicly available.
Can I buy Parvus Therapeutics Inc. stock?
Parvus Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Parvus Therapeutics Inc.'s last funding round?
Parvus Therapeutics Inc.'s most recent funding round was Corporate Funding on March 20, 2024.
Who are the main investors in Parvus Therapeutics Inc.?
Key investors in Parvus Therapeutics Inc. include National Research Council Canada Industrial Research Assistance Program, Innovate Calgary.
Will Parvus Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Parvus Therapeutics Inc..
How can I track Parvus Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Parvus Therapeutics Inc.'s secondary market activity and sign up for updates.